Cuban health regulator CECMED approves the emergency use of the domestically-produced Abdala vaccine, becoming the fifth COVID-19 vaccine to be approved in the country. Manufacturers last month claimed that the vaccine, which requires three doses, has a 92% effectiveness rate against the virus. This makes Cuba the first Caribbean and Latin American country to successfully develop its own variation of the vaccine.
Cuban health regulator CECMED approves the emergency use of the domestically-produced vaccine Abdala, becoming the fifth COVID-19 vaccine to be approved in the country. Manufacturers last month claimed that the vaccine, which requires three shots, has a 92% effectiveness rate against the virus. This makes Cuba the first Caribbean and Latin American country to successfully develop its own variation of the vaccine.
Cuban health regulator CECMED approves the emergency use of the domestically-produced Abdalavaccine, becoming the fifth COVID-19 vaccine to be approved in the country. Manufacturers last month claimed that the vaccine, which requires three doses, has a 92% effectiveness rate against the virus. This makes Cuba the first Caribbean and Latin American country to successfully develop its own variation of the vaccine.
